Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node InvolvementMarch 14, 2025
Volume 27, 2024 Efficacy and Safety of Anlotinib Combined with Single-Agent Chemotherapy in Advanced Primary Immune-Resistant NSCLC: A Retrospective CohortOctober 28, 2024 Yonghong Li1, Wei Li1, Yirui Liu2, Yi Peng3, Jing Tang4 and Xiaobing Li5 Author informationCitations Corresponding author. Correspondence: Prof. Xiaobing…
